Validity and Reliability of a Novel Multimodal Questionnaire for the Assessment of Abdominal Symptoms in People with Cystic Fibrosis (CFAbd-Score)
Author:
Funder
Vertex Pharmaceuticals
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1007/s40271-019-00361-2.pdf
Reference42 articles.
1. Nährlich L, Burkhart M, Wiese B. German CF-Registry, annual report 2015. Gießen; 2016.
2. Ooi CY, Durie PR. Cystic fibrosis from the gastroenterologist’s perspective. Nat Rev Gastroenterol Hepatol. 2016;13(3):175–85. https://doi.org/10.1038/nrgastro.2015.226 .
3. Demeyer S, De Boeck K, Witters P, Cosaert K. Beyond pancreatic insufficiency and liver disease in cystic fibrosis. Eur J Pediatr. 2016;175(7):881–94. https://doi.org/10.1007/s00431-016-2719-5 .
4. Kelly T, Buxbaum J. Gastrointestinal manifestations of cystic fibrosis. Digest Dis Sci. 2015;60(7):1903–13. https://doi.org/10.1007/s10620-015-3546-7 .
5. Borowitz D, Gelfond D. Intestinal complications of cystic fibrosis. Curr Opin Pulmon Med. 2013;19(6):676–80. https://doi.org/10.1097/MCP.0b013e3283659ef2 .
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A grumbling concern: A survey of gastrointestinal symptoms in cystic fibrosis in the modulator era;NIHR Open Research;2024-02-05
2. Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract in Cystic Fibrosis;Current Gastroenterology Reports;2023-12-07
3. A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes.;NIHR Open Research;2023-11-27
4. Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire;Frontiers in Pharmacology;2023-10-25
5. Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome;Microbiology Spectrum;2023-10-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3